Ionis Pharmaceuticals Inc’s filing revealed that its Chief Executive Officer Monia Brett P unloaded Company’s shares for reported $17219.0 on Feb 16 ’24. In the deal valued at $44.49 per share,387 shares were sold. As a result of this transaction, Monia Brett P now holds 173,751 shares worth roughly $7.34 million.
Then, Monia Brett P sold 23,501 shares, generating $1,160,303 in total proceeds. Upon selling the shares at $49.37, the Chief Executive Officer now owns 174,138 shares.
Before that, Cadoret-Manier Onaiza sold 2,125 shares. Ionis Pharmaceuticals Inc shares valued at $105,404 were divested by the EVP, Chf GL Pdt Str & Oper Ofc at a price of $49.60 per share. As a result of the transaction, Cadoret-Manier Onaiza now holds 35,825 shares, worth roughly $1.51 million.
BofA Securities upgraded its Ionis Pharmaceuticals Inc [IONS] rating to a Buy from a a Neutral in a research note published on January 02, 2024; the price target was increased to $62 from $52. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in late October from “an Underperform” to “a Neutral”. Raymond James began covering IONS with “Strong buy” recommendation on September 29, 2023. Citigroup revised its rating on July 31, 2023. It rated IONS as “a Buy” which previously was an “a Neutral”.
Price Performance Review of IONS
On Monday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock fall -2.27% to $42.24. Over the last five days, the stock has lost -3.87%. Ionis Pharmaceuticals Inc shares have fallen nearly -16.51% since the year began. Nevertheless, the stocks have risen 15.44% over the past one year. While a 52-week high of $54.44 was reached on 01/12/24, a 52-week low of $34.32 was recorded on 03/20/24. SMA at 50 days reached $45.73, while 200 days put it at $45.33. A total of 0.87 million shares were traded, compared to the trading of 1.46 million shares in the previous session.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 41.82, which if violated will result in even more drops to 41.40. On the upside, there is a resistance level at 43.05. A further resistance level may holdings at 43.86. The Relative Strength Index (RSI) on the 14-day chart is 40.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.48, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.90%. Stochastics %K at 34.72% indicates the stock is a holding.
How much short interest is there in Ionis Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on Mar 15, 2024, growing by 0.61 million shares to a total of 9.67 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 9.06 million shares. There was a rise of 6.31%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 7.83% of the overall stock float, the days-to-cover ratio (short ratio) rose to 6.79.
